Beta-blockers, ACE inhibitors, ARBs, calcium channel blockers linked to higher adverse event rates. HealthDay News — Commonly used noncancer medications, including proton pump inhibitors, are ...
Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...
Proton pump inhibitors, often called PPIs, are among the most widely used medications for stomach acid problems. Many people ...
Proton pump inhibitor drug omeprazole is widely prescribed in the UK ...
"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results